BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24337061)

  • 1. TWEAK/Fn14 signaling mediates gastric cancer cell resistance to 5-fluorouracil via NF-κB activation.
    Kwon OH; Kim JH; Kim SY; Kim YS
    Int J Oncol; 2014 Feb; 44(2):583-90. PubMed ID: 24337061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome.
    Huang M; Narita S; Tsuchiya N; Ma Z; Numakura K; Obara T; Tsuruta H; Saito M; Inoue T; Horikawa Y; Satoh S; Habuchi T
    Carcinogenesis; 2011 Nov; 32(11):1589-96. PubMed ID: 21828059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil.
    Seo JH; Jeong ES; Lee KS; Heo SH; Jeong DG; Choi YK
    Int J Oncol; 2013 Dec; 43(6):2007-14. PubMed ID: 24100731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
    Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
    Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells.
    Shin JY; Kim JO; Lee SK; Chae HS; Kang JH
    BMC Cancer; 2010 Aug; 10():425. PubMed ID: 20704765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
    Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
    Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated fibroblast growth factor-inducible 14 expression promotes gastric cancer growth via nuclear factor-κB and is associated with poor patient outcome.
    Kwon OH; Park SJ; Kang TW; Kim M; Kim JH; Noh SM; Song KS; Yoo HS; Wang Y; Pocalyko D; Paik SG; Kim YH; Kim SY; Kim YS
    Cancer Lett; 2012 Jan; 314(1):73-81. PubMed ID: 21993017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of nuclear factor-κB activity by small interfering RNA in esophageal squamous cell carcinoma cell lines.
    Hatata T; Higaki K; Nanba E; Tatebe S; Ikeguchi M
    Oncol Rep; 2011 Sep; 26(3):659-64. PubMed ID: 21617867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway.
    Wang D; Fung JN; Tuo Y; Hu L; Chen C
    Cancer Lett; 2010 Aug; 294(1):91-100. PubMed ID: 20189297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of inducible NF-kappaB activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line.
    Uetsuka H; Haisa M; Kimura M; Gunduz M; Kaneda Y; Ohkawa T; Takaoka M; Murata T; Nobuhisa T; Yamatsuji T; Matsuoka J; Tanaka N; Naomoto Y
    Exp Cell Res; 2003 Sep; 289(1):27-35. PubMed ID: 12941601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis.
    Pettersen I; Baryawno N; Abel F; Bakkelund WH; Zykova SN; Winberg JO; Moens U; Rasmuson A; Kogner P; Johnsen JI; Sveinbjörnsson B
    Int J Oncol; 2013 Apr; 42(4):1239-48. PubMed ID: 23443741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Epstein-Barr virus infection to chemoresistance of gastric carcinoma cells to 5-fluorouracil.
    Seo JS; Kim TG; Hong YS; Chen JY; Lee SK
    Arch Pharm Res; 2011 Apr; 34(4):635-43. PubMed ID: 21544729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer.
    Camp ER; Li J; Minnich DJ; Brank A; Moldawer LL; MacKay SL; Hochwald SN
    J Am Coll Surg; 2004 Aug; 199(2):249-58. PubMed ID: 15275881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells.
    Liang X; Shi H; Yang L; Qiu C; Lin S; Qi Y; Li J; Zhao A; Liu J
    Br J Cancer; 2017 Mar; 116(7):903-911. PubMed ID: 28222070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
    Wang W; McLeod HL; Cassidy J; Collie-Duguid ES
    Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors.
    Kadota K; Huang CL; Liu D; Yokomise H; Haba R; Wada H
    Int J Oncol; 2011 Feb; 38(2):355-63. PubMed ID: 21174056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWEAK promotes ovarian cancer cell metastasis via NF-kappaB pathway activation and VEGF expression.
    Dai L; Gu L; Ding C; Qiu L; Di W
    Cancer Lett; 2009 Oct; 283(2):159-67. PubMed ID: 19398263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
    Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.